loadpatents
name:-0.015588045120239
name:-0.018754005432129
name:-0.044498920440674
Benet Buchholz; Jordi Patent Filings

Benet Buchholz; Jordi

Patent Applications and Registrations

Patent applications and USPTO patent grants for Benet Buchholz; Jordi.The latest application filed is for "polymorphic form of a long-acting beta-2 adrenoceptor agonist".

Company Profile
1.9.14
  • Benet Buchholz; Jordi - Altafulla ES
  • Benet-Buchholz; Jordi - Tarragona ES
  • Benet Buchholz; Jordi - Altafulla (Tarragona) ES
  • Benet-Buchholz; Jordi - Leverkusen DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
4-[-2-[[5-methyl-1-(2-naphtalenyl)-1H-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride polymorphs and solvates
Grant RE47,214 - Berenguer Maimo , et al. Ja
2019-01-29
Polymorphic form of a long-acting beta-2 adrenoceptor agonist
Grant 9,309,186 - Benet-Buchholz , et al. April 12, 2
2016-04-12
Crystalline form of abacavir that is essentially free of solvent
Grant 9,056,864 - Bartra Sanmarti , et al. June 16, 2
2015-06-16
4-[-2-[[5-methyl-1-(2-naphtalenyl)-1H-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride polymorphs and solvates
Grant 9,051,275 - Berenguer Maimo , et al. June 9, 2
2015-06-09
Polymorphic Form Of A Long-acting Beta-2 Adrenoceptor Agonist
App 20150087715 - Benet-Buchholz; Jordi ;   et al.
2015-03-26
CO-CRYSTALS OF TRAMADOL AND NSAIDs
App 20140350110 - BUSCHMANN; Helmut Heinrich ;   et al.
2014-11-27
4-[-2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine Hydrochloride Amorphous Solid Forms
App 20130150575 - Benet Buchholz; Jordi ;   et al.
2013-06-13
Salts of Tramadol and Naproxen and their crystal forms in the treatment of pain
Grant 8,168,679 - Buschmann , et al. May 1, 2
2012-05-01
CO-CRYSTALS OF TRAMADOL AND NSAIDs
App 20110257134 - Buschmann; Helmut Heinrich ;   et al.
2011-10-20
Salts Of Tramadol And Ibuprofen And Their Crystal Form In The Treatment Of Pain
App 20110178174 - Buschmann; Helmut Heinrich ;   et al.
2011-07-21
Crystalline form of cyano-1-cyclopropy1-7-1S,6S-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1- ,4-dihydro-4-oxo-3-quinoline carboxylic acid
Grant 7,977,484 - Rast , et al. July 12, 2
2011-07-12
Substituted Heterocycles
App 20110015248 - STADLER; Marc ;   et al.
2011-01-20
Crystalline Form Of Abacavir That Is Essentially Free Of Solvent
App 20100298354 - Bartra Sanmarti; Marti ;   et al.
2010-11-25
Salts Of Tramadol And Naproxen And Their Crystal Forms In The Treatment Of Pain
App 20100227927 - Buschmann; Helmut Heinrich ;   et al.
2010-09-09
Process For Preparing Entacapone Substantially Free Of Z-isomer, Synthesis Intermediates Thereof And A New Crystalline Form
App 20090326062 - Palomo Nicolau; Francisco Eugenio ;   et al.
2009-12-31
Salts Of Substitutted Pyrazoline Compounds, Their Preparation And Use And Medicaments
App 20090149472 - Torrens Jover; Antonio ;   et al.
2009-06-11
Novel Crystalline Form Of Cyano-1-Cyclopropyl-7-1S,6S-2,8-Diazabicyclo[4.3.0]Nonan-8-Yl) -6-Fluoro-1,4-Dihydro-4-Oxo-3-Quinoline Carboxylic Acid
App 20080125458 - Rast; Hubert ;   et al.
2008-05-29
Copper complexes and their use
Grant 7,179,946 - Scholz , et al. February 20, 2
2007-02-20
Substituted heterocycles
App 20060229353 - Stadler; Marc ;   et al.
2006-10-12
Copper complexes and their use
App 20040198997 - Scholz, Ulrich ;   et al.
2004-10-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed